G Medical Innovations Holdings Ltd announced that it has entered into a definitive securities purchase agreement with the purchaser for the issuance of up to 9,009,009 ordinary shares, par value $0.0001 per share of the company for the aggregate gross proceeds of $500,000 on September 29, 2023. Pursuant to the Purchase Agreement, the company will issue additional ordinary shares for an additional aggregate consideration of $500,000 subject to achievement of certain milestones and other terms and conditions set forth in the Purchase Agreement. The first closing is expected to occur within 30 days from the date of this Report of Foreign Private Issuer.